-
The Economic Burden of Overweight and Obesity in Europe: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Patient and Caregiver Recommendations for Person-Centered Oncology Clinical Trial Design: A Qualitative Study
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among High-Risk Adults in Taiwan
Sep 9, 2025, 16:22 PM -
Epidemiological Study of Pulmonary Hypertension in Patients With Interstitial Lung Diseases (PH-ILD) in Greece: A Retrospective Multicenter Study
Sep 9, 2025, 16:22 PM -
Evolution and Geographical Patterns of the Portuguese Newborn Screening Program in the Last 10 Years
Sep 9, 2025, 16:22 PM -
Artificial Intelligence Detection of National Clinical Practice Gaps in Hormone-Sensitive Prostate Cancer (HSPC) in Brazil: A Patient-Centered Framework
Sep 9, 2025, 16:22 PM -
Survival Trends in Multiple Myeloma by Treatment Era in the United States
Sep 9, 2025, 16:22 PM -
Trends in Epidemiology and Mortality of Patients With Bladder Cancer in Germany: A Retrospective Study Using German Claims Data
Sep 9, 2025, 16:22 PM -
Comparison of Clinical Outcome Assessment in Randomized Controlled Trials and in Observational Studies for Amyotrophic Lateral Sclerosis: A Scoping Review
Sep 9, 2025, 16:22 PM -
Structured Expert Elicitation for Survival Outcomes: Insights From NICE Technical Support Document 26
Sep 9, 2025, 16:22 PM -
Trends and Disparities in Prostate Cancer Incidence Prevalence and Survival: A SEER Analysis 2000-2022
Sep 9, 2025, 16:22 PM -
Comparing HTA Outcomes and Rationale for Decision Making Between Countries With Mature vs. Newly Founded HTA Systems: Evidence From England, France, and Greece
Sep 9, 2025, 16:22 PM -
The Artificial Intelligence Era in Health Economic Modeling
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review on Economic Evaluations and Cost-Effectiveness of Second-Line Treatment Options for Immune Thrombocytopenia
Sep 9, 2025, 16:22 PM -
Competing Beyond the First Mover: How Late to Market Analogues Navigate Pricing and Access in Major Global Markets
Sep 9, 2025, 16:22 PM -
Navigating Uncertainty and Pragmatic Acceptance: Canadian Patient and Public Perspectives on Radiopharmaceutical Therapy in the Context of Whole Health
Sep 9, 2025, 16:22 PM -
Alternative Pricing Policies for Multi-Indication Products: A Quantitative Analysis
Sep 9, 2025, 16:22 PM -
Evaluation of Participation Data in the Context of Cancer Prevention
Sep 9, 2025, 16:22 PM -
Randomized Controlled Trials (RCTs) Are the Gold Standard: Are They Always Used?
Sep 9, 2025, 16:22 PM -
The Impact of Inhaler Technique on the Health Outcomes and Cost Among Adults With Asthma and Chronic Obstructive Pulmonary Disease in Saudi Arabia
Sep 9, 2025, 16:22 PM